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Abstract
Human Immunodeficiency Virus Type 1 (HIV-1) establishes a latent reservoir early in infection that is resistant to the host immune response
and treatment with highly active antiretroviral therapy (HAART). The best understood of these reservoirs forms in resting CD4+ T cells. While it
remains unclear how reservoirs form, a popular model holds that the virus can only integrate in activated CD4+ T cells. Contrary to this model, our
previous results suggest that HIV-1 can integrate directly into the genomes of resting CD4+ T cells. However, a limitation of our previous studies
was that they were conducted at high viral inoculum and these conditions may lead to cellular activation or saturation of restriction factors. In the
present study, we tested if our previous findings were an artifact of high inoculum. To do this, we enhanced the sensitivity of our integration assay
by incorporating a repetitive sampling technique that allowed us to capture rare integration events that occur near an Alu repeat. The new
technique represents a significant advance as it enabled us to measure integration accurately down to 1 provirus/well in 15,000 genomes—a 40-
fold enhancement over our prior assay. Using this assay, we demonstrate that HIV can integrate into resting CD4+ T cells in vitro even at low viral
inoculum. These findings suggest there is no threshold number of virions required for HIV to integrate into resting CD4+ T cells.
© 2007 Elsevier Inc. All rights reserved.Keywords: HIV latency; Resting CD4+ T cells; HIV integration; HIV reservoirs; Restriction factorsIntroduction
Human Immunodeficiency Virus-1 (HIV-1) establishes a
latent infection that effectively evades immune surveillance and
drug therapy (Blankson et al., 2002; Chun et al., 1997b; Lassen
et al., 2004; Lehrman et al., 2005; Pierson et al., 2000;
Stevenson, 2003). The best characterized latently infected cells
are resting CD4+ T cells. It is thought that latently infected cells
form when HIV DNA integrates into an activated cell just before
that cell returns to a resting state (Han et al., 2007). This
hypothesis is supported by early findings in vitro (Bukrinsky et
al., 1991; Korin and Zack, 1998; Stevenson et al., 1990; Sun and
Clark, 1999; Unutmaz et al., 1999; Yamashita and Emerman,⁎ Corresponding author.
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doi:10.1016/j.virol.2007.06.0012006; Zack et al., 1990; Zack et al., 1992) and in HIV infected
individuals (Chun et al., 1997a, 1995; Ostrowski et al., 1999).
However, this hypothesis must be reconciled with studies
showing that HIV (and SIV) is produced from CD45RA+ naïve
CD4+ T cells in HIV infected organ cultures (Eckstein et al.,
2001) and in HIV (and SIV) infected individuals (Kinter et al.,
2003a; Nishimura et al., 2005; Zhang et al., 1999). The fact that
HIV is produced from naïve cells suggests that an activation step
may not be required for HIV integration, although it is also
possible that all the CD45RA+ cells that are producing HIV are
not truly naïve (De Rosa et al., 2001) or that naïve cells receive
an activating stimuli that allows productive infection to occur
without causing the cell to switch to the CD45RO isoform.
At odds with the early in vitro findings (Yamashita and
Emerman, 2006), we recently reported that integration does
occur in resting CD4+ T cells inoculated with HIV in vitro
(Swiggard et al., 2005). In this study, we used high viral
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tion frequency. To achieve high viral inoculum conditions, we
used a technique called spinoculation which deposits many
virions to each resting CD4+ T cell (O'Doherty et al., 2000).
Thus, it was possible that the observed integration in resting T
cells was due to these artificial conditions. It was possible that
the high inoculum conditions may have activated the cells
without inducing upregulation of activation markers. Consistent
with this idea, it had been reported that productive infection of
inoculated PBMCs occurs when these cells are exposed to high
concentrations of gp120 (Briant et al., 1996), presumably by
inducing cross-linking of CD4 (Briant et al., 1999; Kinter et al.,
2003b; Kornfeld et al., 1988). Alternatively, it was possible that
depositing many virions per cell could saturate restriction
factors in a manner similar to cross-species saturation of
TRIM5α (Besnier et al., 2002; Best et al., 1996; Keckesova et
al., 2004; Luban, 2007; Stremlau et al., 2004; Towers et al.,
2000, 2002, 2003). Notably, the saturable nature of HIV-1
restriction in resting CD4+ T cells has not been directly
investigated. To address these possibilities, we set out to test
whether a threshold number of virions are required to bind to
resting CD4+ T cells in order for integration to occur. In other
words, we sought to determine if HIV could transduce resting
CD4+ T cells under low virus inoculum conditions. To approach
these questions, we found it necessary to improve our original
integration assay because it lacked the sensitivity required to
detect low levels of provirus (O'Doherty et al., 2002).
In the present study, we increase the sensitivity of our
original integration assay, which used Alu–gag PCR to
distinguish integrated from unintegrated DNA (O'Doherty et
al., 2002). We demonstrate that an inherent limitation of Alu–
gag PCR is variable amplification at low proviral copy number.
As a result, integration is only detectable when HIV inserts
close to an Alu repeat limiting the sensitivity of the Alu–gag
PCR. We go on to show that the sensitivity of our method is
enhanced ∼40-fold by testing samples repetitively. Sampling
repetitively not only reduces the standard deviation, but, more
importantly, it enables us to capture rare integration events
where HIV integrates close to an Alu element. Using the more
sensitive integration assay, based on repetitive sampling, we
demonstrate that integration can occur in resting CD4+ T cells
even under low viral inoculum conditions. These findings
suggest that there is no threshold number of virions required for
integration to occur and that the interaction of a single viral
particle with a resting CD4+ T cell and any stimulus that this
interaction may cause are sufficient for integration of HIV.
Results
Generation of a standard curve demonstrates enhanced
sensitivity with repetitive sampling (Fig. 1)
To calculate HIV integration events, we needed to compare
the level of integration in our unknown samples to a standard
that contained diverse integration sites to accurately reflect
integration in vivo (Butler et al., 2001). We generated an
integration standard cell line (IS) with diverse integration sitesat ∼1 integration event per cell (not shown) using a similar
strategy as our previous work (O'Doherty et al., 2002). The
strategy that we used to determine that there was one integration
event per cell and that all the HIV DNA was integrated is
detailed in Supplement 1 and in Materials and methods. Our
integration assay is based on Alu-PCR, which uses primers for
the repetitive element Alu of the human genome and for the gag
gene of HIV. We then measured the level of Alu–gag signal
generated with the IS and compared it to the signal generated
using only the gag primer, which provides the signal from
unintegrated DNA. We reasoned that we could enhance the
sensitivity of our assay by repetitive sampling to capture single
integration events on the rare occasion that HIV integrated near
to an Alu site. To test this hypothesis and to determine the
sensitivity of our assay when performed repetitively, we serially
diluted our IS DNA in DNA of uninfected PBMCs and then
assayed each dilution 40 times (Fig. 1A). We consistently
assayed total DNA concentrations equivalent to 1.5×104
cells per reaction (IS cells+uninfected PBMC) to maintain a
constant number of Alu sites (see the PCR conditions section of
Materials and methods for explanation). When 160 proviruses
in 1.5×104 genomes were assayed repetitively, the standard
deviation was small and the Alu–gag and gag-only signals did
not overlap. When 80 proviruses per 1.5×104 genomes were
assayed, the standard deviation increased, but integration was
detectable 100% of the time. When less than 40 proviruses per
1.5×104 genomes were assayed, only a fraction of the samples
gave a positive signal, i.e. several Alu–gag signals overlapped
with the gag-only signal. Nonetheless, a reproducible relation-
ship existed between the number of proviruses at low copy
number and the average of the Alu–gag signals. With this assay,
we could detect down to ∼1 provirus per 15,000 genomes 10%
of the time since 4 out of 40 Alu–gag signals were statistically
different from the distribution of the gag-only signals (Alu–gag
signals with a cycle threshold below 26.8 occur with a probability
of less than 0.01, as determined by a one-sample z-test of the
gag-only signals). Thus, the sensitivity of our assay was
increased by about 40-fold since the detection limit of our prior
integration assay was about ∼40–80 proviruses per reaction.
Finally, we determined how the cycle threshold varied with
the number of proviruses by calculating the average Alu–gag
cycle threshold (including the signals that overlapped with the
gag-only signal) and plotting it against the proviral number
for IS. We observed a linear relationship between the natural
logarithm of the proviral number (n) and the natural logarithm
of the average cycle threshold (μ): ln n=−9.6999 ln μ+33.079
with R2 =0.975 (Fig. 1B).
Integration is not detected when HIV inserts far from an Alu
sequence (Fig. 2)
We presumed that the undetectable integration events in Fig.
1 occurred when HIV inserted distantly from the nearest Alu.
We also presumed that the amplification was variable due to the
variable distance between the provirus and the Alu site. To
measure what is the minimum distance between the site of
integration and Alu required for detection in our system, we
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contained unique integration sites at different distances from
Alu. The four clones were isolated by inoculating 293 cells
(IS-293) with VSV-G pseudotyped HIVΔenv at a low multi-
plicity of infection to reduce the chance of individual cells
containing multiple integration sites (in Fig. 1, CEMss cells
were infected while in Fig. 2, 293 cells were infected with VSV-
G pseudotyped HIVΔenv). The polyclonal IS-293 cells were
grown in hygromycin and clones were subsequently isolated by
limiting dilution. After 28 days in culture, clones were FACSsorted to be uniformly GFP positive. First, we confirmed that
each clone had one copy of HIV DNA per cell by quantitative
PCR (data not shown). Next, for each clone, we employed
inverse PCR to clone the HIV integration site as described (Han
et al., 2004) and sequenced it. We then aligned the obtained
sequence to the human genome to find the exact location of the
integration site. We also determined the location of the nearest
Alu (in the correct orientation, with less than 2 mismatches to
our Alu primer and no mismatches in the 3′ end) by sequence
alignment. From these data, we calculated the distance between
the nearest Alu and the HIV integration site (Fig. 2A).
We found that the smaller the distance between the
integration site and the Alu sequence, the greater the Alu–gag
amplification (Fig. 2B). However, when the distance between
the integration site and the nearest Alu sequence was large,
integration was not detected, in other words, there was no
difference between the Alu–gag amplification and the gag-only
primer amplification (Fig. 2B). We did not detect integration
when HIV inserted N∼5000 bp from the nearest Alu using a
2.5 min extension. Thus, the limit for detecting an Alu–gag
amplicon occurs when HIV inserts between 2000 and 5000 bps
from the nearest Alu. While longer extension times would allow
amplification of larger Alu–gag amplicons, the overall
amplification efficiency was not enhanced when we extended
the amplification time beyond 2.5 min (data not shown).
Isolation of highly enriched resting CD4+ T cells (Fig. 3)
With this improved assay, we tested if HIV-1 could integrate
in resting CD4+ T cells when delivered at low inoculum.
Partially purified CD4+ T cells (ppCD4) were obtained from
leukapheresis-enriched PBMC by negative selection rosette and
successfully depleted cells of other lineages (CD8, 16, 19, 36,
56, 66b, TCRγδ) yielding N96% CD4+ T cells (Fig. 3).
However, a significant percentage of these cells expressed
activation markers. The contaminating activated cells were
depletedwithmagnetic beads and antibodies recognizingmarkersFig. 1. Repetitive sampling increases the sensitivity of the integration assay. (A)
DNA from the polyclonal IS was diluted into a constant amount of uninfected
human genomic DNA and subjected to our two-step Alu-PCR. The first PCR
reaction used primers to Alu and gag or only primers to gag. The second PCR
reaction used HIV-1 specific primers to the LTR elements, R and U5. For each
dilution sample, Alu–gag and gag-only (background) amplification was
measured 40 times and the provirus number was determined. At low proviral
copy number, integration is detected at a low frequency as demonstrated by the
Alu–gag amplification. For clarity, we did not show the gag-only signals at the
lower dilutions, but instead show the bracketed black lines ( ) which represent
where the gag-only signal (background) was detected at each proviral number.
(B) A log–log relationship exists between the average cycle threshold value and
the provirus number. Given the provirus number in our integration standard, we
were able to determine the relationship between the average cycle threshold (CT)
value and the provirus number. The average cycle threshold is obtained by
averaging the cycle numbers where each PCR amplification curve crosses the
y=−2.5. After calculating the average CT for IS at several provirus counts, a
linear regression was performed on the natural logarithm of the average CT and
the natural logarithm of the average provirus count to obtain the following
formula: ln(n)≅−9.6999×ln(Ct)+33.079. Each point represents 40 measure-
ments performed at each IS concentration and the error bars represent the
standard deviation.
Fig. 2. Alu–gag amplification depends on the distance between Alu and
integrated virus. Alu–gag amplification efficiency was related to the distance
between the HIV-1 integration site and the nearest Alu sequence. Alu–gag
amplification, and hence integration, was undetectable when HIV-1 integrated
N5000 bp from the nearest Alu site. (A) Four clones (A, B, C, and D) were
derived from polyclonal IS-293. The clones were generated by culturing IS-293
at ∼1 cell/well. For each clone, the distance from the nearest Alu to gag was
determined as described in Materials and methods. (B) Alu–gag amplification
was more efficient when the nearest Alu was close to the integration site and
undetectable when Alu was far from the integration site. DNA from each clone
was subjected to two-step PCR. Alu–gag and gag-only were measured three
times and the response curves for each clone are shown. In every experiment, a
horizontal threshold line was drawn at y=−2.5. The smaller the distance
between HIV-1 gag and Alu, the more efficient the amplification and the lower
the CT (compare A and D). For each clone, the Alu–gag response curves were
compared to the gag-only response curves. When the distance between HIV-1
gag and Alu was N5000 bp, as in clone D, there was no difference between
the Alu–gag signal (integration) and the gag-only signal (background).
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Materials and methods. After the second purification step, less
than 1% of the cells expressed activation markers (Fig. 3,
compare rCD4 with the fluorescence minus one [FMO] control).
Integration of HIV-1 in CD4+ T cells can be detected at low
viral inoculum (Figs. 4 and 5)
We previously demonstrated that HIV-1 can integrate in
resting CD4+ T cells under high inoculum conditions. To test ifHIV-1 could integrate at low inoculum, we serially diluted our
viral stocks and then inoculated Tcells under routine conditions.
We first tested the ability of a VSV-G pseudotyped HIV-1 to
integrate into CD4+ T cells when delivered at low inoculum.
ppCD4 (Fig. 3) were infected with 3-fold serial dilutions of
pNL4-3 VSV-G by standard inoculation for 2 h at 25 °C. After
inoculation, samples from high and low inoculation conditions
were collected to assess the level of viral binding by measuring
the p24 antigen level with an ELISA (O'Doherty et al., 2000).
The cells were subsequently cultured for 3 days to allow
integration to occur in the presence of 1.25 μM of saquinavir to
ensure the infection was limited to a single round. The cells
were then harvested and genomic DNAwas purified to measure
the total number of cells based on the number of β-globin genes
present (O'Doherty et al., 2000). We then measured the level of
integration in 1.5×104 cells with our improved Alu-PCR assay.
As shown in Fig. 4, integration occurred under low inoculum
conditions and decreased in a dose-dependent manner. In the
same way, the number of reverse transcripts per cell (RU5/cell)
decreased in a dose-dependent manner (Figs. 4C, D). Similarly,
a dose-dependent decrease in reverse transcription and integra-
tion were observed when cells were spinoculated with the same
stock of diluted virus (Supplement 2).
In order to determine the validity of the dose response, we
plotted the logarithm of the proviral count and the dilution. The
logarithmic conversion of the data revealed a linear relationship
as expected with a dose-response and allowed us to determine
the R2 value (R2 =0.99). In addition, we detected, on average,
less than 1 virion/cell (0.36 virions/cell) at the end of the
inoculation with the most dilute virus (based on p24) and still
detected integration (0.0005 proviruses/cell) (Fig. 4A, dark bars
with asterisks). This suggests that there is no requirement for a
threshold number of virions to be bound per cell for successful
integration. In summary, a dose dependent decrease was
obtained over a 3 log range of viral inoculums, ranging from
800 virions bound per cell down to ∼1 virion bound per 3 cells
at the end of the inoculation (Fig. 4 and Supplement 2).
We next tested if a threshold effect exists using purer resting
CD4+ T cells (rCD4) inoculated with wild type HIV-1 (Fig. 5).
It was important to determine if we obtained the same results
with wildtype HIV-1 since VSV-G-mediated entry differs
significantly from gp120-mediated entry. It was also important
to confirm that we detected integration in the resting fraction of
circulating CD4+ T cells as circulating blood CD4+ T cells
(ppCD4) represent a range of activation states. Consistent with
the observations made for pseudotyped HIV-1, a dose-
dependent decrease in integration and reverse transcription
occurred in resting CD4+ T cells inoculated with pNL4-3.
Integration could be inhibited by 98% and reverse transcription
could be inhibited by 92% in the presence of AZT (added at the
top dose). We estimated that ∼3 virions were bound per cell at
the top dilution, at the end of inoculation, based on p24 ELISA
(not shown). This corresponds to a multiplicity of infection
(MOI) of 0.02 as assessed by infection of CEMss-GFP indicator
cells. We also tested the inoculated resting CD4+ T cells for
upregulation of CD69, CD25 and HLA-DR before and 3 days
after inoculation and found no detectable staining at either time
Fig. 3. Purification of resting CD4+ T cells. PBMC (enriched by leukapheresis) were negatively depleted by RBC rosette using antibodies against: Glycophorin A,
CD8, 16, 19, 36, 56, 66b and TCRγδ to yield N96% partially purified CD4
+ T cells (ppCD4). ppCD4 were then stained with PE-labeled antibodies with specificities for
HLA-DR, CD25 and CD69 in order to deplete activated cells with anti-PE magnetic beads. Purified resting CD4+ T cells (rCD4) contain less than 1% activated T cells.
The gates were placed based on fluorescence minus one (FMO) controls, which were only labeled with anti-CD4. The gates were set conservatively such that 1% of
unstained cells were in the upper quadrants. The above figure represents a typical purification of resting CD4+ T cells.
64 L.M. Agosto et al. / Virology 368 (2007) 60–72point (not shown, but consistent with our previous study
(Swiggard et al., 2005)). In our prior report, no activation was
detected by three distinct methods. There was no BrdU
incorporation over a 72 h incubation period, no change in cell
cycle by DNA/RNA stain and no change in activation markers.
These studies were performed at higher inoculums compared to
the current study and so we presume that there is less activation
in the current study.Fig. 4. Integration of HIV-1 in CD4+ T cells is detected at low viral inoculum. A dose
viral inoculum (A, B). ppCD4 cells were inoculated with three-fold dilutions of supe
asterisk represent the number of virions bound per cell. The top and bottom viral dil
(O'Doherty et al., 2000). Cells were inoculated by routine inoculation for 2 h at 25 °C
serial dilution of the viral inoculum. The results are presented in provirus per cell (A)
The level of viral integration and reverse transcripts are shown as log(3) to convert the
the standard deviation of 5–51 measurements of integration and 4–8 measurements
number (and sample availability). More repeats were required to capture integration
written above each point (B, D).Both resting and intermediately activated CD4+ T cells are
equally susceptible to HIV-1 integration at low inoculum
conditions (Fig. 6)
Circulating CD4+ T cells have a range of activation states. In
our prior publication, we showed that the integration signal we
obtained in resting CD4+ T cells could not be due to rare
contaminating strongly activated CD4+ T cells. However, low-dependent decrease in viral integration was observed with serial dilution of the
rnatant containing VSV-G pseudotyped pNL4-3. The dark bars indicated by an
utions correspond to 16 and 0.36 virions/cell respectively based on p24 ELISA
. A dose-dependent decrease in RU5 reverse transcripts was also observed with
, log(3) of provirus per cell (B), RU5 per cell (C, D) and log(3) RU5 per cell (D).
exponential relationship (A,C) to a linear relationship (B,D). Error bars represent
of reverse transcripts, respectively, for each virus dilution depending on proviral
events at low proviral numbers. The number of proviruses/cell and RU5/cell are
Fig. 5. Integration of wild type HIV-1 in pure resting CD4+ T cells exhibits a
dose-dependent decrease in integration and reverse transcription with each
dilution. A dose-dependent decrease in viral integration (A) and reverse
transcription (B) was observed with serial dilution of the viral inoculum. Resting
CD4+ T cells were inoculated with two-fold dilutions of supernatant containing
pNL4-3. Cells were inoculated by routine inoculation for 2 h at 25 °C. After
infection, the cells were cultured for 72 h before measuring integration. The
results are presented in log(2) of provirus per cell (A) and log(2) of RU5 per cell
(B). For integration, the error bar at the top dilution represents the standard error
of 5 independent inoculations. Each inoculation at the top dilution was measured
for viral integration 10–12 times depending on sample availability. The error
bars of the lower dilutions represent the standard deviation of 12–42
measurements of integration for each virus dilution depending on sample
availability. In general more replicates were performed at the lower dilutions.
For reverse transcription, the error bar at the top dilution represents the standard
error of 5 independent inoculations. Each inoculation at the top dilution was
measured for reverse transcription 2–6 times depending on sample availability.
The error bars of the lower dilutions represent the standard deviation of 4–6
measurements of reverse transcription for each virus dilution depending on
sample availability. The number of proviruses/cell and RU5/cell are written
above each point.
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predominant contaminants in our purified resting CD4+ T
cells. To test if the signal we obtained in our resting CD4+ T
cells could be attributed to contaminating intermediately
activated cells we compared the susceptibility of intermediately
activated CD4+ T cells relative to resting cells. Resting and
intermediately activated cells were sort purified from PBMC
using the FACS Aria (Fig. 6). Conservative gates were set
around the lineage (FITC) and activation (PE) double negative
population to separate resting cells from the lineage negative
and activation intermediate population. Post-sort analysis of
these populations showed that resting cells were 98% pure and
that intermediately activated cells were 94% pure. Immediately
after sorting, both populations of cells were infected with serial
dilutions of pNL4-3. We estimated, by p24 binding assay
(O'Doherty et al., 2000), that approximately 3 virions werebound per cell (not shown) when the resting and intermediately
activated cells were inoculated with 1:9 dilution of the viral
stock, demonstrating that our experiments were conducted at
low inoculum. Reverse transcription and integration were
measured at the peak of reverse transcription and integration
which occurred 24 h after inoculation in stimulated cells and
48–72 h after inoculation in resting and intermediately activated
cells.
Reverse transcription is more efficient in stimulated cells
than in resting or intermediately activated cells (Fig. 7). Reverse
transcription occurred 10 times more efficiently in the CD3 and
CD28 stimulated cells. In this experiment, integration occurred
with similar efficiency in resting, intermediately activated and
stimulated cells since approximately 1 in 5 reverse transcripts
integrated. Our data overall however (including prior work
(Swiggard et al., 2005)) suggest that integration is slightly more
efficient in activated cells as we find between 1 in 2 and 1 in 5
reverse transcripts integrate in activated cells and between 1 in 5
and 1 in 13 reverse transcripts integrate in resting CD4+ T cells.
Discussion
In the present study, we increase the sensitivity of our
original, Alu–gag PCR-based, HIV integration assay (O'Doh-
erty et al., 2002) by applying a repetitive sampling technique.
Using the new assay, we demonstrate that HIV integrates into
resting CD4+ T cells even under low viral inoculum conditions.
We find a dose-dependent decrease in the level of integration
suggesting that there is no threshold number of virions required
to bind to a CD4+ T cell for integration to occur. A threshold
effect seemed likely since high viral inoculums might activate
CD4+ T cells (Briant et al., 1996; Kornfeld et al., 1988) or
possibly saturate a restriction factor that might be present in
resting CD4+ T cells.
We used the new, more sensitive integration assay to test if
integration can occur under low inoculum conditions. Integra-
tion occurs (albeit at low levels, e.g.∼5 in 10,000 CD4+ T cells,
Fig. 4) even when, on average, less than one virion was bound
per T cell at the end of the inoculation. Similar observations
were noted when we inoculated pure resting CD4+ T cells with
wild type HIV-1 at comparable low inoculum, i.e. less than one
virion bound per T cell at the end of the inoculation (∼2 in
10,000 cells, Fig. 5). It could be argued that the rare integration
events that we detect under low inoculum are due to integration
events in rare activated T cells. However, we demonstrated that
intermediately activated cells, which are the predominant
contaminants among our purified resting cells, have the same
susceptibility to integration as resting cells and so contaminat-
ing intermediately activated cells could not account for the
signal. In addition, our prior work (Swiggard et al., 2005)
demonstrated that rare activated cells contributed less than 5%
to the integration signal detected in resting T cells when infected
at high viral inoculum. Finally, while it can be argued that
circulating CD4+ T cells represent a continuum of activation
states, it has been shown that resting CD4+ T cells in blood
represent the low end of that continuum (Stefanova et al., 2002)
and so represent the least activated cell that HIVencounters. Our
Fig. 6. Sorting strategy to obtain highly pure resting and intermediately activated CD4+ T cells. Resting and intermediately activated CD4+ T cells were sort-purified
from PBMC by FACS Aria. PBMC were stained with FITC-labeled antibodies against lineage markers (CD8, CD14, CD16, CD20, CD56) and PE-labeled antibodies
against activation markers (CD25, CD69, HLA-DR)(pre-sort). Gates were set around the double negative and activation intermediate populations to obtain 98% and
94% pure resting and intermediately activated CD4+ T cells respectively (post-sort).
Fig. 7. Both resting and intermediately activated CD4+ T cells have similar
susceptibility to HIV-1 integration. Resting, intermediately activated and
stimulated CD4+ T cells were infected with 3-fold dilutions of the same
pNL4-3 stock, but a different stock of virus than in Fig. 5. After infection, the
cells were cultured for 48 (resting and intermediately activated) or 24 h
(stimulated) before measuring integration (A) and reverse transcription (B). The
level of reverse transcription was determined using primers that detect the
second strand transfer step (SST/cell). Both resting and intermediately activated
cells had similar susceptibility to HIV-1 integration and reverse transcription
while stimulated cells were more susceptible. Error bars represent the standard
deviation of 8–15 measurements of integration and duplicate measurements of
reverse transcription depending on sample availability. The number of pro-
viruses/cell and SST/cell are written above each point.
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cells, the majority of circulating CD4+ T cells, are transduced
with similar susceptibility (Fig. 7).
Our observation that HIV can integrate into resting CD4+ T
cells under low virus inoculum conditions suggests that there is
no threshold number of virions required to bind to a CD4+ T cell
for integration to occur. Instead of a threshold, there is a dose-
dependent decrease in the level of integration (as well as viral
binding and reverse transcription when tested). If a threshold
number of virions were required for integration to occur, we
would expect that at the threshold dilution there would be a
greater decrease in the level of integration. While our data
suggest that there is no threshold effect, our data are still
consistent with the possibility that non-saturable restriction
factors, possibly APOBEC3G/F, play a role during infection of
resting cells (Chiu et al., 2005). For example, the kinetics of
reverse transcription and integration are slower in resting T cells
than in activated T cells (Chiu et al., 2005; Pierson et al., 2002;
Spina et al., 1995; Swiggard et al., 2004; Zack et al., 1990, 1992)
consistent with restriction of an early step in the HIV life cycle.
Our study demonstrating that HIV integration occurs in
resting CD4+ T cells is at odds with many prior studies that
suggest an activation step is required (Bukrinsky et al., 1992;
Ducrey-Rundquist et al., 2002; Korin and Zack, 1998; Oswald-
Richter et al., 2004; Stevenson et al., 1990; Sun and Clark,
1999; Swingler et al., 2003; Unutmaz et al., 1999; Verhoeyen et
al., 2003; Yamashita and Emerman, 2006; Zack et al., 1990,
1992; Zhou et al., 2005). Prior studies show that reverse
transcription (Zack et al., 1990, 1992), nuclear import
(Bukrinsky et al., 1992; Sun and Clark, 1999) and integration
(Stevenson et al., 1990) are blocked in resting T cells. In
addition, the fact that integrated HIV DNA is enriched in
memory over naïve CD4+ T cells in HIV infected individuals
suggests that a prior activation step allowed integration to occur
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current study we tested if HIV integration into resting CD4+ T
cells was an artifact of spinoculation or high inoculum. To the
contrary, we establish that integration still occurs in resting
CD4+ T cells in the absence of spinoculation and under low
inoculum conditions.
The discrepancy between our results and the literature may
be explained by considering two issues: delayed kinetics and
assay sensitivity. The early studies that demonstrate a block in
HIV reverse transcription (Zack et al., 1990, 1992), nuclear
import (Bukrinsky et al., 1992; Sun and Clark, 1999) and
integration (Stevenson et al., 1990) in resting CD4+ T cells were
all performed within 24 h of inoculation, but the kinetics are
delayed in resting CD4+ T cells and viral intermediates are
detected more easily after 2–3 days of culture (Chiu et al., 2005;
Pierson et al., 2002; Spina et al., 1995; Swiggard et al., 2004). In
addition, the prior integration assays were probably not
sufficiently sensitive to detect integration under routine
inoculation conditions. For example, we would not be able to
detect integration in any of the samples inoculated under routine
conditions from Fig. 5 using our previous standard integration
assay (O'Doherty et al., 2002). The infection frequency in
resting CD4+ T cells in our hands (Swiggard et al., 2005, 2004)
and others (reviewed by (Yamashita and Emerman, 2006)) is
lower than in fully activated T cells such as the CEMss cell line.
Thus, it would be possible to detect integration in fully activated
T cells, but not in resting T cells.
Notably, our study is in agreement with in vivo studies
showing that naïve CD4+ T cells are productively infected in
vivo (Schacker et al., 2001; Zhang et al., 1999) and in lymphoid
organ cultures (Eckstein et al., 2001). In addition, the
predominant infection of “apparently resting” memory CD4+
T cells during acute SIV infection also argues for a role of direct
infection of resting CD4+ T cells (Li et al., 2005; Zhang et al.,
2004). Recently, a second study also reported that integration
occurs in resting CD4+ T cells (Vatakis et al., 2007) albeit at
lower levels. In our study, the fraction of reverse transcripts that
integrate in resting CD4+ T cells vary from about 1 in 5 to about
1 in 10, which is higher than the fraction reported by Vatakis et
al. The difference between our findings and those reported by
Vatakis et al., may be related to differences in viral DNA
stability. Although we and Vatakis et al. reported that viral DNA
can be stable in resting T cells (Swiggard et al., 2004; Vatakis et
al., 2007), we have found the stability of viral DNA to be
variable, depending on the blood donor, day of donation and
virus used (unpublished observations). In addition, the dis-
crepancy in the results may also be related to slight differences
in the assays for integration that were used. Nonetheless, the two
studies are similar in two important ways. One, both studies
found that integration occurs in resting CD4+ T cells. Two, both
studies found that the proportion of reverse transcripts that
integrate in resting and activated T cells are comparable or only
slightly less efficient in resting CD4+ T cells.
Our original Alu–gag PCR-based HIV integration assay had
an inherent limitation: it lacked the ability to detect all
integration events due to the fact that exponential amplification
cannot occur when HIV integrates far from an Alu repeat. Weovercame this limitation by applying a repetitive sampling
technique in combination with a proper integration standard. By
repetitively sampling an integration standard we control for
undetectable integration events and variable amplification
efficiency. In addition, by repetitively sampling our unknowns,
we enhance our ability to capture rare integration events. From
Fig. 1A, we estimate that we detect a single provirus in
15,000 genomes approximately 10% of the time (i.e. 4 out of 40
Alu–gag replicates are above the gag-only signal when we
assay on average ∼1 provirus per well repetitively). This is a
reasonable result since HIV will only occasionally insert near
the Alu sequence (Schroder et al., 2002). We estimate that
repetitive sampling enhances the sensitivity of our assay ∼40-
fold since we can detect 40–80 proviruses per well in 100% of
the wells (with 15,000 cells per well) without repetitive
sampling and 1 provirus per well with repetitive sampling
(Fig. 1A). This represents a significant advance over prior
techniques (Kumar et al., 2002): linker ligation PCR (Vande-
graaff et al., 2001), Alu PCR (Brussel et al., 2005; Brussel and
Sonigo, 2003; Butler et al., 2001; O'Doherty et al., 2002;
Ostrowski et al., 1999; Sonza et al., 1996; Suzuki et al., 2003;
Yamamoto et al., 2006) and inverse PCR (Chun et al., 1997a;
Chun et al., 1995), which are similar conceptually and have the
same inherent limitation—that only a fraction of integration
events should be detectable due to variable amplicon size. This
study is the first to show how genomic anchor based integration
assays perform at low proviral copy with multiple repeats. Some
studies, including our own (O'Doherty et al., 2002), claimed
high sensitivities without showing repetitive sampling at low
copy number. For example, in our prior study (O'Doherty et al.,
2002), we overestimated the sensitivity of our assay by not
recognizing the importance of multiple repeats at low copy
number (and by not diluting our standard in a background of
genomic DNA). Our current study demonstrates that multiple
repeats are absolutely necessary at low proviral numbers to
determine the true sensitivity of an integration assay.
The evidence presented here suggests that there is no
threshold number of bound virions required for HIV integration
to occur in CD4+ T cells. Thus, a single viral particle can
interact with a resting CD4+ T cell and result in integration. In
other words, the direct interaction of virus with a resting CD4+
T cell may be sufficient for latent infection to occur. We propose
that repetitive sampling as exploited in our new method to
measure HIV integration may provide a step toward measuring
integration in patient samples more accurately. We are currently
applying this technique to patient samples in an attempt to
measure more accurately the relative susceptibility of different
cell types.
Materials and methods
Cell lines, plasmids, and viruses
The CD4+ T-lymphoblastoid cell line CEM-ss was main-
tained at 1–5×105 cells per ml. The culture medium used was
RPMI 1640 supplemented with 10% heat-inactivated fetal
bovine serum, 25 mM HEPES, with 100 μg/ml penicillin–
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typed (Blumenthal et al., 1987; Emi et al., 1991) virions were
collected 24 h after Ca3(PO4)2 transfection of 293T cells with
pVSVg (pHIT) (Fouchier et al., 1997) and pNL4-3Δenv/GFP/
HygR. The reporter virus was derived from pNL4-3, an X4-
tropic molecular clone of HIV (Adachi et al., 1986). The nef
open reading frame (orf) was replaced with a GFP and
hygromycin cassette which contained an internal ribosome
entry site between the two orfs. The transfection supernatants
were treated with 30 μg/ml of DNase I (Roche) and 10 mM
MgCl2 at 37 °C, 1 h prior to collection. For the infections at low
inoculum, pNL4-3 and pNL4-3 VSV-G were used from 293T
cell Ca3(PO4)2 transfection supernatant.
Preparation of the Integration Standard (IS) cell line
CEM-ss cells were infected with pseudotyped virions
(described above) by spinoculation. Briefly, 2×107 CEM-ss
cells were mixed with 1 ml of viral stock (VSVg pseudotyped
pNL4-3Δenv/GFP/HygR containing 1 μg/ml p24 Gag protein)
and placed into one well of a flat-bottom six-well tissue culture
plate. The plates were sealed in plastic bags and centrifuged in
microplate carriers at 1200×g for 2 h at 25 °C. Cells were
collected and washed once with 50 ml of ice-cold culture
medium (RPMI1640 with 10% heat-inactivated fetal calf
serum, 10 mM HEPES, 1% penicillin–streptomycin (Gibco)).
Infected cells were cultured for 2 days and then weaned into
800 μg/ml of hygromycin. The acutely infected cells contained
unintegrated HIV-1 DNA and integrated proviral DNA. With
every cell division, the level of unintegrated DNA per cell
decreased while the integrated proviral DNA replicated with
cellular DNA. After 28 days in culture, the level of unintegrated
DNA became undetectable by Southern blot as demonstrated in
our previous work (O'Doherty et al., 2002) and the GFP
positive transduced cells were selected by FACS sorting.
Preparation of clones with unique HIV integration sites
293 cells were infected with VSVg pseudotyped reporter
virus pNL4-3Δenv/GFP/HygR at a low multiplicity of infection
to minimize the chance of multiple transductions within one
cell. The 293 cells were grown for 2 days and then weaned into
hygromycin at 800 μg/ml. After hygromycin selection and
expansion, the transduced 293 cells were sorted for expression
of GFP. Clonal populations with unique HIV integration sites
were prepared by culturing cells at b1 cell/well. Hygromycin
was added to the wells after single cell cloning. Clones which
grew in hygromycin were again sorted for expression of GFP.
After sorting the GFP positive cells, we measured the level of
HIV DNA per cell using quantitative PCR and found ∼1 copy
of HIV per cell consistent with one transduction event per cell.
Identification of unique integration sites within clonal
populations
Inverse PCR was used to clone the integration sites as
described (Han et al., 2004). Briefly DNA was prepared andcleaved by Pst1 which cuts genomic DNA frequently, but cleaves
pNL4-3Δenv/GFP/HygR once at position 1419 (HXB2R coordi-
nates). Digested DNA was then ligated under dilute conditions
to favor intramolecular ligation. Outwardly directed primers to
LTR and gag are designed to exponentially amplify circular
DNA. Thus, host genomic DNA adjacent to the HIV-1
insertion site was amplified along with the 5′ end of the HIV
genome. The amplified DNA was cloned and sequenced after a
nested reaction again with outward primers. The genomic
insertion site was determined by aligning the sequence with the
human genome sequence. The nearest Alu sequence that
matched the Alu primer with less than 2 base pair mismatches
was located.
PCR conditions to measure proviral number
Two-step PCR amplification was performed as described
(O'Doherty et al., 2002) with some modifications. Briefly, the
first amplification was performed on dilutions of the IS cells as
well as samples from infected CD4+ Tcells. The sequence of the
first step amplification primers were: genomic Alu forward 5′
GCC TCC CAA ACT GCT GGG ATTACA G-3′ and HIV gag
reverse 5′ GTT CCT GCT ATG TCA CTT CC-3′. The gag
primer is different from the previously described primer
(O'Doherty et al., 2002). It provides a better consensus
sequence than the original primer, based on Los Alamos HIV
Sequence Database, and provides more efficient Alu–gag
amplification. DNA from the Integration Standard cell line
(IS) was diluted in uninfected peripheral blood mononuclear
cells (PBMC) DNA at 2 μg/ml to keep the number of Alu sites
per reaction constant. We kept the number of Alu sites constant
because the first-step PCR amplification efficiency increased
with decreasing number of Alu sites. If we diluted the IS DNA
in buffer our assay would inaccurately appear to be more
sensitive. By diluting IS DNA in uninfected PBMC DNA, we
mimic the conditions of low infection frequency. For similar
reasons, we cannot simply add more cellular DNA to enhance
the sensitivity of our assay since the sensitivity decreased as the
number of cells per sample increased. In other words, increased
numbers of Alu sites decreased the amplification efficiency. We
also reasoned that keeping the number of genomes low
minimizes PCR inhibition which occurred more frequently at
higher concentrations of genomes.
Reactions were carried out in a volume of 50 μl containing:
10 mM Tris–HCl, pH 8.3; 3 mM MgCl2; 1 mM mixed dNTPs;
50 mM KCl; 100 nM Alu forward primer; 600 nM gag reverse
primer; and 0.05 units of Platinum Taq DNA polymerase
(Invitrogen Life Technologies). The thermal cycler (DNA
Engine Opticon, MJResearch) was programmed to perform a
2-min hot start at 95 °C, followed by 20 cycles: denaturation at
95 °C for 15s, annealing at 50 °C for 15s and extension at 72 °C
for 2.5 min. The Alu primer binds only to cellular genomic
DNA, not to unintegrated HIV DNA; the gag primer binds to
one strand of HIV DNA. When both Alu and gag primers are
used in the amplification, the original template strands and
every copy are duplicated in each round, so amplification
becomes exponential. Linear, one-strand amplification (i.e.
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amplification PCR with the gag primer alone. When only the
gag primer is used, only one strand of the original template
DNA is copied so amplification is linear. We used the gag-only
primer amplification reaction as a control because it provides
the signal expected from unintegrated HIV DNA. While
increased extension times increases the ability of Taq
polymerase to make longer amplicons, the overall amplification
efficiency was maximal at 2.5 min of extension.
The second round real-time quantitative PCR was performed
using 25 μl of the material from the first amplification. These
were run with an HIV-1 copy number standard. The sequences of
the primers were: LTR (R) forward, 5′-GCC TCA ATA AAG
CTT GCC TTG A-3′; LTR (U5) reverse, 5′-TCC ACA CTG
ACT AAA AGG GTC TGA-3′. The LTR molecular beacon
probe, labeled at its 5′ terminus with the reporter fluorophore 6-
carboxyfluorescein (FAM) and at its 3′ terminus with the
quencher 4-(4′-dimethylamino-phenylazo)-benzene (DAB-
CYL), had the following sequence: 5′-FAM-GCG AGT GCC
CGT CTG TTG TGT GAC TCT GGT AAC TAG CTC GC-
DABCYL-3′. Reactions were carried out in a volume of 50 μl
containing: 10 mM Tris–HCl, pH 8.3; 75 mM KCl; 5.5 mM
MgCl2; 1.2 mM freshly added dNTPs, 250 nMLTR forward and
reverse primers; 200 nMmolecular beacon probe; and 0.05 units
of Platinum Taq DNA polymerase. The reactions were
performed on a DNA Engine Opticon (MJResearch) instrument
running Opticon Monitor v1.1 software with the following
thermal program: 2 min hot start at 95 °C, 4 cycles of
denaturation at 95 °C for 15 s, annealing at 50 °C for 15 s, and
extension at 72 °C for 1 min followed by 44 cycles of
denaturation for 15 s, annealing at 50 °C for 15 s, plate read, and
lastly extension at 72 °C for 1 min.
To express integration as a ratio of proviruses per target cell,
a kinetic PCR assay for β-globin DNA was used as described
(O'Doherty et al., 2000). A standard curve is made using
purified DNA from PBMC (Qiagen). The quantity of DNA is
determined by OD260/280. The number of genomes is calculated
given that ∼3.18×109 bp are present per genome. Minus strand
strong stop DNA (RU5/cell) and the level of DNA that has
completed the second strand transfer step of reverse transcrip-
tion (SST/cell) were measured as previously described
(O'Doherty et al., 2002; Swiggard et al., 2005).
Repetitive sampling to measure integration at low proviral
copy number
Alu–gag PCR and gag-only PCR were performed repeti-
tively on 25 μl aliquots of DNA at 2 μg/ml from the IS line and
samples from infected CD4+ T cells. Then HIV-1 specific
kinetic PCR is performed on 25 μl aliquot of the first reaction.
After the kinetic PCR reaction, the cycle thresholds (Ct) for
each well are determined, i.e. the cycle value where the
accumulating fluorescence (from fluorescently labeled ampli-
cons) crosses a specified fluorescent threshold value. In all of
the experiments described here, the fluorescent threshold value
was set at −2.5 for data analysis. The cycle threshold values
from each concentration of IS and for each sample were thenaveraged. The average cycle thresholds from the IS with known
proviral count were then used to determine the relationship
between the average cycle threshold and the proviral count
(Fig. 1B). The proviral number from samples was then
calculated by inputting the average cycle threshold into the
equation described in Fig. 1B.
Purification of resting and intermediately activated
CD4+ T cells
For the studies testing if a threshold number of virions is
required for integration, CD4+ T cells were isolated by
negative selection from leukapheresis-enriched PBMC by
rosette (RosetteSep kit, StemCell Technologies, Inc.) as
recommended by the manufacturer. Briefly, leukapheresis-
enriched PBMC were labeled with antibodies recognizing
Glycophorin A, CD8, CD16, CD19, CD36, CD56, CD66b and
TCRγδ. A secondary anti-mouse antibody was added to cross-
link labeled PBMC to labeled red blood cells. Following these
labeling steps, the cells were applied to a Ficoll-Paque® (GE
Healthcare) density gradient to remove the cross-linked cell
complexes. Resting CD4+ T cells were then isolated by
negative selection with saturating concentrations of PE-labeled
antibodies specific for HLA-DR, CD25, and CD69 (BD
Pharmingen) and anti-PE magnetic beads (Miltenyi Biotec) as
recommended by the manufacturers. After purification, the
cells were cultured overnight in RPMI 1640 culture medium
supplemented with 10% heat inactivated human serum and 1%
penicillin–streptomycin (Gibco).
For the studies comparing the susceptibility of resting and
intermediately activated CD4+ T cells, the cells were sort
purified as described (Swiggard et al., 2005) but using a FACS
Aria instrument (BD Biosciences). Briefly, PBMCwere isolated
from whole blood by Ficoll-Paque® (GE Healthcare) density
gradient. Cells were subsequently labeled with saturating
amounts of FITC-labeled antibodies recognizing lineage
markers (CD8, CD14, CD16, CD20, CD56) and PE-labeled
antibodies recognizing activation markers (CD25, CD69, HLA-
DR). The double negative population, corresponding to resting
cells, and the cells expressing intermediate levels of activation
markers were selected. Immediately after sorting the cells were
washed once with PBS containing 10% human serum and
resuspended in the appropriate viral supernatant for immediate
infection.
Flow cytometry
To determine the level of purity and activation, the cells were
stained in FACS buffer (PBS with 1%BSA and 2 mM EDTA)
with 10% human serum and mouse IgG to block non-specific
binding, and antibodies recognizing CD3, CD4, HLA-DR,
CD25 and CD69 (BD Pharmingen). The labeled cells were then
screened by flow cytometry with a FACScalibur instrument
(BD Biosciences). The results were later analyzed with FlowJo
software (Treestar). Dot plot gates were set based on an un-
labeled control, single positive controls, and fluorescence minus
one controls (FMO) missing one of the labels. We set our
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gave a positive signal in order to detect low levels of staining.
Stimulation of CD4+ T cells
A portion of the sort-purified cells were selected to be
stimulated prior to infection. Cells were cultured for 72 h in the
presence of CD3/CD28 beads at 3 beads per cell, and 10 U/ml
of recombinant human IL-2. After incubation, the beads were
removed with a magnet, the cells were washed once with PBS
containing 10% human serum and resuspended in the appro-
priate viral supernatant.
Inoculation of primary CD4+ T cells
Purified CD4+ T cells were resuspended at 1×107 cells/ml in
100 μl of serially diluted viral supernatants. Cells were then
inoculated at 1xg or spinoculated at 1200×g (O'Doherty et al.,
2000) for 2–3 h at 25 °C. Following inoculation, the cells were
washed twice with PBS containing 10% human serum and
cultured in RPMI 1640 culture medium supplemented with 10%
human serum, 1% penicillin–streptomycin (Gibco), and
1.25 μM saquinavir (Roche US Pharmaceuticals) for 24, 48
or 72 h. Selected samples were treated with 100 μg/ml zido-
vudine (AZT) (NIH AIDS Reagents Program) to inhibit reverse
transcription as a negative control.
Assessment of viral binding
Viral binding was assessed by measuring the level of p24Gag
associated with the samples collected immediately after
inoculation as previously described (O'Doherty et al., 2000).
p24Gag levels were measured by p24-specific enzyme-linked
immunosorbent assay (ELISA; Coulter Corporation, Miami,
FL) with little cross-reactivity to other viral proteins. Binding
was subsequently calculated based on the estimation that
15,800 virions are present per 1 pg of p24 (O'Doherty et al.,
2000; Vogt and Simon, 1999). This method provides a good
estimate of viral binding, although it may overestimate the
number of infectious virions bound per cell due to the presence
of virus-like particles without genomes or inactive virions. The
limit of sensitivity of our p24 assay is 8 pg/ml and so to detect
viral binding at our lowest inoculum (∼1 virion per 3 cells),
400,000 cells/ml would be required, but 1×106 cells/ml were
generally used at the lowest inoculum to ensure that the signal
fell in the range of detection.
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